Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

USFDA approves expanded indication for AbbVie Mavyret for Acute Hepatitis C Virus

Written By Ruchika Sharma15 Jun 2025 12:00 PM IST

North Chicago: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for a label expansion for MAVYRET...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca collaborates with CSPC Pharma focused on AI-enabled research

Written By Ruchika Sharma15 Jun 2025 11:00 AM IST

Cambridge: AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.Working...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older

Written By Ruchika Sharma15 Jun 2025 10:00 AM IST

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use...

Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035

Syngene International Bengaluru facility successfully completes USFDA inspection

Written By Ruchika Sharma14 Jun 2025 1:00 PM IST

Bengaluru: In a BSE filing, Syngene International has informed that the company's facility at Semicon Park, Bengaluru has successfully...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma gets 8 USFDA observations for Halol facility

Written By Ruchika Sharma14 Jun 2025 11:05 AM IST

Mumbai: Sun Pharmaceutical Industries Limited has announced that US Food and Drugs Administartion (USFDA) has issued eight observations for its Halol...

Granules India packaging facility in US successfully completes USFDA inspection

USFDA issues one observation for Natco Pharma Mekaguda unit

Written By Ruchika Sharma14 Jun 2025 10:00 AM IST

Hyderabad: NATCO Pharma Limited has announced that the company has received one observation from the United States Food and Drugs Administration...

Moderna gets USFDA nod for RSV Vaccine mRESVIA in adults aged 18-59 at increased risk for RSV disease

Written By Ruchika Sharma13 Jun 2025 11:49 AM IST

Cambridge: Moderna, Inc. has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for mRESVIA...

Merck begins Phase 3 study for Dengue vaccine candidate

Written By Ruchika Sharma13 Jun 2025 11:00 AM IST

Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is a significant health...

Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC

Bharat Biotech to lead further development of GSK Shigella vaccine

Written By Ruchika Sharma12 Jun 2025 3:26 PM IST

Hyderabad: Bharat Biotech International Limited has announced that it has partnered with GSK plc for the ongoing development and potential use of...

Zydus gets USFDA EIR for Ankleshwar API facility

Written By Ruchika Sharma12 Jun 2025 11:54 AM IST

Ahmedabad: Zydus has announced that the company has received the Establishment Inspection Report (EIR) report from the US Food and Drugs...

Novo Nordisk, Deep Apple Therapeutics ink pact to develop oral therapeutics for Cardiometabolic Diseases

Written By Ruchika Sharma12 Jun 2025 10:00 AM IST

South San Francisco: Deep Apple Therapeutics, Inc. has announced a research collaboration and exclusive worldwide license agreement with Novo...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer, Broad Institute extend research collaboration to develop new cardiovascular therapies

Written By Ruchika Sharma11 Jun 2025 1:15 PM IST

Berlin: Bayer and the Broad Institute have extended their research collaboration of 10 years by an additional five years, to further advance...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok